The global in-vitro colorectal cancer screening tests market is projected to grow from USD 1,000 million in 2025 to USD 1,310 million by 2034, expanding at a CAGR of 3.05% during the forecast period. Increasing colorectal cancer cases, technological advancements in CRC DNA tests, and government-backed screening programs are fueling the market's steady rise.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: In-vitro Colorectal Cancer Screening Tests Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. In-vitro Colorectal Cancer Screening Tests Market, by Test Type
8.1.1. Fecal Occult Blood Test
8.1.1.1. Market Revenue and Forecast
8.1.2. CRC DNA Screening Test
8.1.2.1. Market Revenue and Forecast
8.1.3. Biomarker Test
8.1.3.1. Market Revenue and Forecast
9.1. In-vitro Colorectal Cancer Screening Tests Market, by End-user
9.1.1. Clinics
9.1.1.1. Market Revenue and Forecast
9.1.2. Hospital
9.1.2.1. Market Revenue and Forecast
9.1.3. Diagnostic Laboratories
9.1.3.1. Market Revenue and Forecast
9.1.4. Others
9.1.4.1. Market Revenue and Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, by Test Type
10.1.2. Market Revenue and Forecast, by End-user
10.1.3. U.S.
10.1.3.1. Market Revenue and Forecast, by Test Type
10.1.3.2. Market Revenue and Forecast, by End-user
10.1.4. Rest of North America
10.1.4.1. Market Revenue and Forecast, by Test Type
10.1.4.2. Market Revenue and Forecast, by End-user
10.2. Europe
10.2.1. Market Revenue and Forecast, by Test Type
10.2.2. Market Revenue and Forecast, by End-user
10.2.3. UK
10.2.3.1. Market Revenue and Forecast, by Test Type
10.2.3.2. Market Revenue and Forecast, by End-user
10.2.4. Germany
10.2.4.1. Market Revenue and Forecast, by Test Type
10.2.4.2. Market Revenue and Forecast, by End-user
10.2.5. France
10.2.5.1. Market Revenue and Forecast, by Test Type
10.2.5.2. Market Revenue and Forecast, by End-user
10.2.6. Rest of Europe
10.2.6.1. Market Revenue and Forecast, by Test Type
10.2.6.2. Market Revenue and Forecast, by End-user
10.3. APAC
10.3.1. Market Revenue and Forecast, by Test Type
10.3.2. Market Revenue and Forecast, by End-user
10.3.3. India
10.3.3.1. Market Revenue and Forecast, by Test Type
10.3.3.2. Market Revenue and Forecast, by End-user
10.3.4. China
10.3.4.1. Market Revenue and Forecast, by Test Type
10.3.4.2. Market Revenue and Forecast, by End-user
10.3.5. Japan
10.3.5.1. Market Revenue and Forecast, by Test Type
10.3.5.2. Market Revenue and Forecast, by End-user
10.3.6. Rest of APAC
10.3.6.1. Market Revenue and Forecast, by Test Type
10.3.6.2. Market Revenue and Forecast, by End-user
10.4. MEA
10.4.1. Market Revenue and Forecast, by Test Type
10.4.2. Market Revenue and Forecast, by End-user
10.4.3. GCC
10.4.3.1. Market Revenue and Forecast, by Test Type
10.4.3.2. Market Revenue and Forecast, by End-user
10.4.4. North Africa
10.4.4.1. Market Revenue and Forecast, by Test Type
10.4.4.2. Market Revenue and Forecast, by End-user
10.4.5. South Africa
10.4.5.1. Market Revenue and Forecast, by Test Type
10.4.5.2. Market Revenue and Forecast, by End-user
10.4.6. Rest of MEA
10.4.6.1. Market Revenue and Forecast, by Test Type
10.4.6.2. Market Revenue and Forecast, by End-user
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Test Type
10.5.2. Market Revenue and Forecast, by End-user
10.5.3. Brazil
10.5.3.1. Market Revenue and Forecast, by Test Type
10.5.3.2. Market Revenue and Forecast, by End-user
10.5.4. Rest of LATAM
10.5.4.1. Market Revenue and Forecast, by Test Type
10.5.4.2. Market Revenue and Forecast, by End-user
11.1. Abbott Molecular
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. BioMarCare Technologies
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Eiken Chemical
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Epigenomics AG
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Exact Sciences Corporation
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Immunostics
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Novigenix
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. OncoCyte Corporation-Bio time
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Quest Diagnostics
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Randox Laboratories
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
13.1. About Us
13.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
Schedule a Meeting
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Get a Sample
Report Description
Get a Sample
Report Description